Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
US8685370B2 · kind B2 · utility
19Cited by
0References
46Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 13, 2009 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Sep 12, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/574
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a family of agents that target integrins, which can be used as imaging agents and/or therapeutic agents. The agents can be used to image angiogenesis, inflammation or other physiological processes in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.